UPSC Articles
Tata CRISPR Test
Part of: GS Prelims and GS-II – Health & GS-III – Achievements of Indians in Sci & Technology
In news
- India’s first CRISPR Covid-19 test, developed by the Tata Group and CSIR-IGIB, has been approved for use in India.
Key takeaways
- The Tata CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) test is powered by CSIR-IGIB (Institute of Genomics and Integrative Biology) FELUDA.
- This test uses an indigenously developed, cutting-edge CRISPR technology for detection of the genomic sequence of SARS-CoV-2 virus.
- CRISPR is a genome editing technology for diagnosing diseases.
- It is the world’s first diagnostic test to deploy a specially adapted Cas9 protein to successfully detect the virus causing Covid-19.
- It achieves accuracy levels of traditional RT-PCR tests, with quicker turnaround time, less expensive equipment, and better ease of use.
